This compound is a key intermediate in the pharmaceutical industry, used in the synthesis of various active pharmaceutical ingredients (APIs) for psychotropic drugs targeting neurological and psychiatric disorders, such as anxiety, depression, and schizophrenia. Its dibenzoazepine core structure facilitates the development of molecules that modulate neurotransmitter systems like serotonin and norepinephrine. The fumarate salt enhances solubility, stability, and handling during synthesis and formulation processes. It is primarily employed in research and manufacturing settings, and any potential applications in therapeutics derive from the APIs it helps produce. Use should be under professional supervision to ensure safety and compliance.